Supplemental Materials for No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study

    May 2026 in “ Mendeley Data
    Archie Spindler

    We don't know much about this study yet.

    Discuss this study in the Community →